180 related articles for article (PubMed ID: 33567764)
21. Cripto-1: an embryonic gene that promotes tumorigenesis.
de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
[TBL] [Abstract][Full Text] [Related]
22. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.
Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A
Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966
[TBL] [Abstract][Full Text] [Related]
23. CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
Terry S; El-Sayed IY; Destouches D; Maillé P; Nicolaiew N; Ploussard G; Semprez F; Pimpie C; Beltran H; Londono-Vallejo A; Allory Y; de la Taille A; Salomon DS; Vacherot F
Oncotarget; 2015 May; 6(14):11994-2008. PubMed ID: 25596738
[TBL] [Abstract][Full Text] [Related]
24. Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.
Colas JF; Schoenwolf GC
Gene; 2000 Sep; 255(2):205-17. PubMed ID: 11024280
[TBL] [Abstract][Full Text] [Related]
25. Cripto: a tumor growth factor and more.
Adamson ED; Minchiotti G; Salomon DS
J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442
[TBL] [Abstract][Full Text] [Related]
26. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
27. Role of the EGF-CFC gene cripto in cell differentiation and embryo development.
Minchiotti G; Parisi S; Liguori GL; D'Andrea D; Persico MG
Gene; 2002 Apr; 287(1-2):33-7. PubMed ID: 11992720
[TBL] [Abstract][Full Text] [Related]
28. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
[TBL] [Abstract][Full Text] [Related]
29. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M
Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343
[TBL] [Abstract][Full Text] [Related]
30. A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors.
Baldassarre G; Tucci M; Lembo G; Pacifico FM; Dono R; Lago CT; Barra A; Bianco C; Viglietto G; Salomon D; Persico MG
Tumour Biol; 2001; 22(5):286-93. PubMed ID: 11553858
[TBL] [Abstract][Full Text] [Related]
31. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
Saloman DS; Bianco C; Ebert AD; Khan NI; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick WJ; Persico G
Endocr Relat Cancer; 2000 Dec; 7(4):199-226. PubMed ID: 11174844
[TBL] [Abstract][Full Text] [Related]
32. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
33. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.
Minchiotti G; Parisi S; Liguori G; Signore M; Lania G; Adamson ED; Lago CT; Persico MG
Mech Dev; 2000 Feb; 90(2):133-42. PubMed ID: 10640699
[TBL] [Abstract][Full Text] [Related]
34. Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.
Ronca R; Benzoni P; De Luca A; Crescini E; Dell'Era P
Int J Mol Sci; 2012; 13(4):5254-5277. PubMed ID: 22606042
[TBL] [Abstract][Full Text] [Related]
35. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
Kenney NJ; Adkins HB; Sanicola M
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009
[TBL] [Abstract][Full Text] [Related]
36. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
37. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
38. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.
Hentschke M; Kurth I; Borgmeyer U; Hübner CA
J Biol Chem; 2006 Nov; 281(44):33497-504. PubMed ID: 16954206
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity.
Iaccarino E; Calvanese L; Untiveros G; Falcigno L; D'Auria G; Latino D; Sivaccumar JP; Strizzi L; Ruvo M; Sandomenico A
Biochem J; 2020 Apr; 477(8):1391-1407. PubMed ID: 32215602
[TBL] [Abstract][Full Text] [Related]
40. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1.
Hamada S; Watanabe K; Hirota M; Bianco C; Strizzi L; Mancino M; Gonzales M; Salomon DS
Biochem Biophys Res Commun; 2007 Mar; 355(1):240-4. PubMed ID: 17291450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
